New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has turned down the proposal of Dr Reddy’s Laboratories Ltd to conduct a large study in India to evaluate Russia’s Sputnik-V COVID-19 vaccine and has asked it to first test the vaccine in a smaller trial.
An expert panel of the CDSCO stated that since safety and immunogenicity data from early-stage studies conducted overseas is small with no inputs on Indian participants, the vaccine’s large scale test cannot be allowed.
It will be a setback for Russia’s plan to market the vaccine even before full trials. The Russian Direct Investment Fund (RDIF), which is marketing the Sputnik V, and Dr. Reddy’s Laboratories last month announced their partnership to run clinical trials and distribute the vaccine in India.
Russia was the first country to grant regulatory approval for the vaccine even before large scale trials were complete, leading to concerns among scientists and doctors about the safety and efficacy of the shot.
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…